What is the diagnosis for dengue fever presenting with black tarry stool (melena)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dengue Hemorrhagic Fever with Gastrointestinal Bleeding

When a patient with dengue fever presents with black tarry stool (melena), the diagnosis is dengue hemorrhagic fever (DHF) with upper gastrointestinal bleeding, representing a severe manifestation that requires immediate hospitalization and intensive monitoring. 1, 2

Understanding the Clinical Significance

Melena in dengue indicates upper gastrointestinal hemorrhage and qualifies as a danger sign requiring urgent medical attention. 1 This presentation places the patient in the category of dengue with warning signs or severe dengue, depending on hemodynamic status and other complications. 1, 2

Key Diagnostic Considerations

The presence of melena in dengue typically indicates one of two underlying pathologies:

  • Peptic ulcer disease (gastric or duodenal ulcers) - Most common cause, found in approximately 50% of dengue patients with upper GI bleeding. 3 Dengue acts as a precipitating factor for peptic ulcer bleeding due to hemostatic derangements including thrombocytopenia and coagulopathy. 3

  • Hemorrhagic gastritis or gastroduodenal erosions - The second most common finding on endoscopy in dengue patients with melena. 3

Critical laboratory findings that accompany this presentation include: 1, 4

  • Thrombocytopenia (platelet count typically <100,000/mm³, with bleeding risk significantly increased when <70,000/mm³) 4
  • Rising hematocrit with concurrent thrombocytopenia (indicating plasma leakage) 1
  • Prolonged prothrombin time (INR >2.0) and partial thromboplastin time (>60 seconds) 4

Immediate Management Priorities

Resuscitation and stabilization take precedence: 5, 2

  • Hemodynamic assessment - Check blood pressure, pulse pressure (narrow pulse pressure ≤20 mmHg indicates impending shock), heart rate, and capillary refill time. 1, 2

  • Fluid resuscitation - If signs of shock are present (hypotension, narrow pulse pressure, cold extremities), administer 20 mL/kg isotonic crystalloid bolus over 5-10 minutes with immediate reassessment. 2 For severe shock with pulse pressure <10 mmHg, consider colloid solutions. 2

  • Blood product support - Transfuse packed red blood cells to maintain hemoglobin >7 g/dL (target 9 g/dL if massive bleeding or cardiovascular comorbidities). 5 Correct coagulopathy with fresh frozen plasma if INR >1.5 and platelet transfusion if platelets <50,000/mm³ with active bleeding. 5

  • Nasogastric tube insertion - Protect the airway and decompress the stomach in patients with hematemesis or massive melena. 5

Diagnostic Workup

Upper endoscopy (esophagogastroduodenoscopy) is beneficial and recommended to identify structural gastroduodenal lesions when dengue is complicated by hematemesis or melena. 4 This should be performed once the patient is hemodynamically stable. 3

Important pitfall to avoid: Do not assume all bleeding is purely from dengue-related thrombocytopenia. Approximately 50% of dengue patients with upper GI bleeding have underlying peptic ulcer disease that requires specific treatment. 3

Risk Factors for Bleeding

Specific factors that increase bleeding risk in dengue patients include: 4

  • Prior antiplatelet drug use (aspirin, clopidogrel) - significantly increases bleeding risk and should be stopped immediately 4, 6
  • Platelet count <70,000/mm³ 4
  • INR >2.0 4
  • Partial thromboplastin time >60 seconds 4
  • NSAID use - must be discontinued to minimize bleeding risk 6

Monitoring Requirements

These patients require hospitalization with intensive monitoring: 1, 2

  • Daily complete blood count to track platelet counts and hematocrit levels 2
  • Continuous monitoring for other warning signs: persistent vomiting, abdominal pain/tenderness, clinical fluid accumulation, lethargy/restlessness, hepatomegaly 1
  • Hemodynamic parameters every 2-4 hours initially 2
  • Urine output monitoring (target >0.5 mL/kg/hour in adults) 2

Treatment Approach

Supportive therapy forms the cornerstone of management: 3

  • Blood transfusions as needed to maintain adequate hemoglobin 3
  • Fluid management to maintain perfusion while avoiding over-resuscitation (which can worsen plasma leakage) 1, 2
  • Acetaminophen for fever (never aspirin or NSAIDs) 2, 6
  • Proton pump inhibitors for peptic ulcer disease if identified 3

Surgical intervention is rarely required - only one patient in a series of 26 dengue patients with upper GI bleeding required surgery for massive duodenal ulcer bleeding. 3 Most cases resolve with supportive therapy and blood transfusions alone. 3

Prognosis

With appropriate recognition and management, mortality can be reduced to <0.5%. 1 Complete recovery typically occurs within 6 weeks, though the critical period is days 3-7 of illness when warning signs typically appear and progression to severe dengue occurs. 1, 7

References

Guideline

Danger Signs of Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Upper gastrointestinal bleeding in dengue fever.

The American journal of gastroenterology, 1991

Research

Prevalence, patterns, and factors associated with bleeding tendencies in dengue.

Journal of infection in developing countries, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dengue hemorrhagic fever in a British travel guide.

Journal of the American Academy of Dermatology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.